Back to results
US 2006/0052429 A1Published application
Oromucosal formulation and process for preparing the same
AssigneeSanthera Pharmaceuticals (Switzerland) Ltd.
InventorsJuha-Matti Savola, Paivi Juujarvi, Jukka Ilkka
Life of this patent
Estimating the term…
Abstract
An oromucosal formulation containing as an active ingredient a substituted imidazole derivative of formula (I) where Y is —CH2— or —CO—, R1 is halogen or hydroxy, R2 is H or halogen and R3 is H or lower alkyl, or an acid addition salt of this imidazole derivative, and a process for its preparation.
Claims13
1-10. (canceled)
An oromucosal formulation comprising as an active ingredient a substituted imidazole derivative of formula (I)
- where Y is —CH2— or —CO—, R1 is halogen or hydroxy, R2 is H or halogen and R3 is H or lower alkyl, or an acid addition salt thereof.
Dependencies are inferred from the claim text.